| Literature DB >> 30299467 |
Qingyun Li1, Nicholas K Gabler1, Crystal L Loving2, Stacie A Gould1, John F Patience1.
Abstract
The objective of this study was to evaluate the effects of dietary xylanase (X) and a carbohydrase enzyme blend (EB: cellulase, β-glucanase, and xylanase) on nutrient digestibility, intestinal barrier integrity, inflammatory status, and growth performance in weaned piglets fed higher fiber diets. A total of 460 pigs (6.43 ± 0.06 kg BW; F25 × 6.0 Genetiporc) were blocked by initial BW and pens (n = 12 per treatment) were randomly assigned to 1 of 4 dietary treatments. The diets included a higher fiber unsupplemented control diet (CON) and the CON supplemented with 0.01% X, 0.01% EB, or both enzymes, arranged in a 2 × 2 factorial. The diets were based on corn, soybean meal, corn distillers dried grains with solubles (DDGS), and wheat middlings. Pigs had 7 d to adapt to the environment and consumed the same commercial diet. Pigs were fed the experimental diets for 28 d with free access to feed and water. Body weight and feed disappearance were recorded weekly. One pig with BW closest to the pen average from each pen was selected and moved to metabolism crates on day 16 and intragastric gavaged a solution of lactulose and mannitol on day 22 followed by 12-h urine collection. Feces were collected from day 23 to 25. Intestinal tissues and mucosal scrapings were collected on day 28. Data were analyzed using PROC MIXED of SAS (9.4). Xylanase, EB, and their interaction were fixed effects and block was a random effect. The EB, but not X, increased pig BW and improved ADG over 28 d (P < 0.05). Neither carbohydrase impacted ADFI, G:F, or apparent total tract digestibility (ATTD) of DM, GE, or CP. The EB improved ATTD of ADF (32.45 vs. 26.57%; P < 0.01), but had no effect on NDF. Unexpectedly, X reduced ATTD of NDF and ADF (P < 0.01). The EB reduced urinary lactulose:mannitol and increased ileal claudin-3 mRNA abundance (P < 0.05), indicating improved small intestinal barrier integrity. There was a X × EB interaction on ileal secretory immunoglobulin A (sIgA) concentration (P < 0.05); in the absence of X, EB decreased sIgA compared to CON, but this effect disappeared in the presence of X. The EB also reduced ileal IL-22 mRNA abundance (P < 0.05), probably indicating decreased immune activation. In conclusion, EB but not X enhanced growth rate of weaned pigs fed higher fiber diets, which may be partly explained by the improved small intestinal barrier integrity and reduced immune activation, rather than improvement in nutrient digestibility.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30299467 PMCID: PMC6276555 DOI: 10.1093/jas/sky383
Source DB: PubMed Journal: J Anim Sci ISSN: 0021-8812 Impact factor: 3.159
Ingredients and chemical composition of the basal diet (as-fed basis)1
| Item | Phase 1 | Phase 2 |
|---|---|---|
| Ingredients, % | ||
| Corn | 48.11 | 49.80 |
| Reduced-oil corn DDGS | 5.00 | 10.00 |
| Wheat middlings | 5.00 | 10.00 |
| Milk whey powder | 7.50 | - |
| Menhaden select fish meal | 5.80 | 2.00 |
| Hamlet protein, HP 3002 | 8.00 | 3.00 |
| Soybean meal, 47.7 | 17.50 | 22.00 |
| Soybean oil | 0.60 | 0.60 |
| Limestone | 0.58 | 1.05 |
| L-Lys HCl | 0.42 | 0.48 |
| DL-Met | 0.14 | 0.08 |
| L-Thr | 0.09 | 0.11 |
| L-Trp | 0.02 | 0.02 |
| Phytase3 | 0.0125 | 0.0125 |
| Vitamin premix4 | 0.25 | 0.25 |
| Trace mineral premix5 | 0.15 | 0.15 |
| Tiamulin6 | 0.18 | - |
| Chlortetracycline 507 | 0.40 | - |
| Carbadox8 | - | 0.20 |
| Salt | 0.25 | 0.25 |
| Calculated nutrient levels, % | ||
| ME, Mcal/kg | 3.35 | 3.29 |
| NE, Mcal/kg | 2.43 | 2.37 |
| CP | 23.86 | 22.49 |
| NDF | 9.58 | 13.33 |
| ADF | 3.73 | 4.99 |
| SID9 Lys | 1.45 | 1.31 |
| SID Met | 0.50 | 0.40 |
| SID Met + Cys | 0.80 | 0.69 |
| SID Thr | 0.85 | 0.77 |
| SID Trp | 0.26 | 0.23 |
| Total Ca | 0.74 | 0.63 |
| Total P | 0.67 | 0.57 |
| STTD P | 0.56 | 0.44 |
DDGS = distillers dried grains with soluble.
1Phase 1 = day 0–14; Phase 2 = day 14–28; 0.01% xylanase or a carbohydrase enzyme blend or both were mixed with premixes and then added to the basal diets; for use in the metabolism trial from day 16 to 25, 0.40% titanium dioxide as an indigestible marker was mixed with 99.60% of each of the Phase 2 diets.
2Enzymatically treated soybean meal, Hamlet Protein Inc., Findlay, OH.
3OptiPhos 4000 G, Huvepharma Inc., Peachtree City, GA; assumed to release 0.15% standardized total tract digestible (STTD) P in the diet based on manufacture’s recommendation.
4Provided 6,614 IU vitamin A, 827 IU vitamin D, 26 IU vitamin E, 2.6 mg vitamin K, 29.8 mg niacin, 16.5 mg pantothenic acid, 5.0 mg riboflavin, and 0.023 mg vitamin B12 per kg of diet.
5Provided 165 mg Zn (zinc sulfate), 165 mg Fe (iron sulfate), 39 mg Mn (manganese sulfate), 17 mg Cu (copper sulfate), 0.3 mg I (calcium iodate), and 0.3 mg Se (sodium selenite) per kg of diet.
6Denagard 10 (tiamulin, 22 g per kg), Elanco Animal Health, Greenfield, IN.
7Aureomycin 50 (chlortetracycline, 110 g per kg), Zoetis Inc., Kalamazoo, MI.
8Mecadox 2.5 (carbadox, 5.5 g per kg), Phibro Animal Health Corp., Ridgefield Park, NJ.
9SID = standardized ileal digestible.
Analyzed nutrient composition of Phase 2 diets1 (day 14–28; as-fed basis)
| Item | Control | X | EB | X+EB |
|---|---|---|---|---|
| DM, % | 90.15 | 90.74 | 90.68 | 90.31 |
| GE, Mcal/kg | 4.07 | 4.09 | 4.08 | 4.06 |
| CP, % | 21.88 | 22.06 | 22.17 | 22.09 |
| aEE2, % | 4.51 | 4.57 | 4.50 | 4.46 |
| NDF, % | 11.04 | 10.74 | 11.09 | 11.16 |
| ADF, % | 2.87 | 2.76 | 3.08 | 2.99 |
| TiO2, % | 0.37 | 0.40 | 0.37 | 0.38 |
1X: Diet with 0.01% xylanase; EB: Diet with 0.01% a carbohydrase enzyme blend; X+EB: Diet with both enzymes at 0.01%; for use in the metabolism trial from day 16–25, 0.40% titanium dioxide as an indigestible marker was mixed with 99.60% of each of the Phase 2 diets.
2Acid-hydrolyzed ether extract (aEE).
Primers used for real-time quantitative PCR
| Gene | Primer sequence, 5→3′ | Product size, base pair | Accession no. | |
|---|---|---|---|---|
| Forward | Reverse | |||
| IL-1β | TTGAATTCGAGTCTGCCCTGT | CCCAGGAAGACGGGCTTT | 76 | NM_214055 |
| IL-6 | GGCTGTGCAGATTAGTACC | CTGTGACTGCAGCTTATCC | 124 | AF518322 |
| IL-10 | TGGGTTGCCAAGCCTTGT | GCCTTCGGCATTACGTCTTC | 61 | L20001 |
| IL-17 | CCAGACGGCCCTCAGATTAC | CACTTGGCCTCCCAGATCAC | 103 | AB102693 |
| IL-22 | AAGCAGGTCCTGAACTTCAC | CACCCTTAATACGGCATTGG | 133 | AY937228 |
| Occludin | TCGTCCAACGGGAAAGTGAA | ATCAGTGGAAGTTCCTGAACCA | 95 | NM_001163647 |
| Claudin-3 | TTGCATCCGAGACCAGTCC | AGCTGGGGAGGGTGACA | 85 | NM_001160075 |
| ZO-11 | CTCTTGGCTTGCTATTCG | AGTCTTCCCTGCTCTTGC | 197 | XM_003353439 |
| RPL192 | AACTCCCGTCAGCAGATCC | AGTACCCTTCCGCTTACCG | 147 | AF435591 |
1ZO-1 = zonula occluden-1.
2RPL19 = ribosomal protein - L19.
Effect of xylanase (X) and a carbohydrase enzyme blend (EB) on BW of weaned pigs, kg1
| Day | X2 | EB3 | SEM |
| ||||
|---|---|---|---|---|---|---|---|---|
| - | + | - | + | X | EB | X × EB | ||
| 0 | 6.50 | 6.47 | 6.44 | 6.53 | 0.21 | 0.888 | 0.645 | 0.890 |
| 7 | 7.95 | 7.97 | 7.83 | 8.09 | 0.20 | 0.892 | 0.209 | 0.581 |
| 14 | 11.60 | 11.65 | 11.43 | 11.82 | 0.20 | 0.774 | 0.063 | 0.448 |
| 21 | 15.47 | 15.51 | 15.26 | 15.72 | 0.21 | 0.861 | 0.027 | 0.350 |
| 28 | 19.88 | 19.95 | 19.59 | 20.24 | 0.21 | 0.749 | 0.002 | 0.404 |
1 n = 24 pens per treatment (main effects); data were analyzed using repeated measurements; week was significant (P < 0.05), and no X × EB × Week interaction (P > 0.10).
2Xylanase activity was expected to be 15,000 EPU/g and inclusion rate was 0.01% according to the manufacturer’s recommendation.
3One gram EB was expected to contain 7,000 CU of cellulase, 5,000 U of β-glucanase, and 1,000 EPU of xylanase; the inclusion rate of EB was 0.01% according to the manufacturer’s recommendation.
Effect of xylanase (X) and a carbohydrase enzyme blend (EB) on growth performance of weaned pigs1
| Item | X2 | EB3 | SEM |
| ||||
|---|---|---|---|---|---|---|---|---|
| - | + | - | + | X | EB | X × EB | ||
| ADG, kg | ||||||||
| Day 0–7 | 0.21 | 0.21 | 0.20 | 0.22 | 0.01 | 0.922 | 0.168 | 0.676 |
| Day 8–14 | 0.51 | 0.52 | 0.50 | 0.52 | 0.01 | 0.425 | 0.066 | 0.762 |
| Day 15–21 | 0.53 | 0.55 | 0.53 | 0.55 | 0.01 | 0.170 | 0.049 | 0.177 |
| Day 22–28 | 0.64 | 0.65 | 0.64 | 0.64 | 0.01 | 0.679 | 0.942 | 0.315 |
| Average | 0.47 | 0.48 | 0.47 | 0.48 | 0.01 | 0.237 | 0.026 | 0.926 |
| ADFI, kg | ||||||||
| Day 0–7 | 0.27 | 0.26 | 0.26 | 0.27 | 0.002 | 0.799 | 0.518 | 0.792 |
| Day 8–14 | 0.57 | 0.57 | 0.56 | 0.58 | 0.002 | 0.990 | 0.483 | 0.606 |
| Day 15–21 | 0.78 | 0.79 | 0.78 | 0.80 | 0.002 | 0.647 | 0.433 | 0.671 |
| Day 22–28 | 0.99 | 1.04 | 1.03 | 1.01 | 0.002 | 0.026 | 0.453 | 0.826 |
| Average | 0.65 | 0.67 | 0.66 | 0.66 | 0.001 | 0.388 | 0.647 | 0.741 |
| G:F | ||||||||
| Day 0–7 | 0.77 | 0.80 | 0.77 | 0.80 | 0.01 | 0.047 | 0.201 | 0.753 |
| Day 8–14 | 0.90 | 0.91 | 0.91 | 0.90 | 0.01 | 0.628 | 0.802 | 0.605 |
| Day 15–21 | 0.69 | 0.69 | 0.68 | 0.69 | 0.01 | 0.704 | 0.540 | 0.342 |
| Day 22–28 | 0.64 | 0.62 | 0.63 | 0.64 | 0.01 | 0.295 | 0.486 | 0.653 |
| Average | 0.75 | 0.76 | 0.75 | 0.76 | 0.01 | 0.317 | 0.184 | 0.698 |
1 n = 24 pens per treatment (main effect) for weekly data and 96 for 28-d average data; data were analyzed using repeated measurements of weeks; week was significant (P < 0.05), and no X × EB × Week interaction (P > 0.10).
2Xylanase activity was expected to be 15,000 EPU/g and the inclusion rate of X was 0.01% according to the manufacturer’s recommendation.
3One gram EB was expected to contain 7,000 CU of cellulase, 5,000 U of β-glucanase, and 1,000 EPU of xylanase; the inclusion rate of EB was 0.01% according to the manufacturer’s recommendation.
Effect of xylanase (X) and a carbohydrase enzyme blend (EB) on apparent total tract digestibility of dietary constituents, %1,2
| Item | X3 | EB4 | SEM |
| ||||
|---|---|---|---|---|---|---|---|---|
| - | + | - | + | X | EB | X × EB | ||
| DM | 83.79 | 83.59 | 83.45 | 83.93 | 0.28 | 0.600 | 0.225 | 0.966 |
| GE | 82.30 | 82.11 | 82.04 | 82.37 | 0.33 | 0.700 | 0.488 | 0.965 |
| CP | 83.66 | 83.94 | 83.21 | 84.39 | 0.56 | 0.726 | 0.151 | 0.705 |
| aEE5 | 62.82 | 61.05 | 61.78 | 62.10 | 0.68 | 0.073 | 0.737 | 0.285 |
| NDF | 48.95 | 46.10 | 47.11 | 47.94 | 0.65 | 0.004 | 0.375 | 0.535 |
| ADF | 31.71 | 27.30 | 26.57 | 32.45 | 1.09 | 0.008 | 0.001 | 0.824 |
| Hemicellulose | 55.23 | 52.77 | 54.26 | 53.74 | 0.53 | 0.003 | 0.494 | 0.273 |
1Fecal samples were collected on day 23–25 and stored at −20 °C until analysis; pigs were housed in metabolism crates and had free access to feed and water.
2 n = 24 pigs per treatment (main effects).
3Xylanase activity was expected to be 15,000 EPU/g and the inclusion rate of X was 0.01% according to the manufacturer’s recommendation.
4One gram EB was expected to contain 7,000 CU of cellulase, 5,000 U of β-glucanase, and 1,000 EPU of xylanase; the inclusion rate of EB was 0.01% according to the manufacturer’s recommendation.
5Acid-hydrolyzed ether extract (aEE).
Figure 1.Main effect of xylanase (X) and a carbohydrase enzyme blend (EB) on urinary lactulose:mannitol based on percent recovery basis; X: P = 0.788; EB: P = 0.003; X × EB: P = 0.191; n = 24 per treatment (main effects).
Figure 2.Interaction effect of xylanase (X) and a carbohydrase enzyme blend (EB) on ileal mucosal secretory immunoglobulin A (sIgA) concentration; X+EB: diets with both X and EB; a,bMeans without a common superscript differ (P < 0.05); n = 12 per treatment.
Effect of xylanase (X) and a carbohydrase enzyme blend (EB) on mRNA abundance of cytokines and tight junction proteins in the ileum1,2
| Gene | X3 | EB4 | SEM |
| ||||
|---|---|---|---|---|---|---|---|---|
| - | + | - | + | X | EB | X × EB | ||
| IL-1ß | 1.00 | 0.96 | 1.09 | 0.87 | 0.12 | 0.141 | 0.527 | 0.453 |
| IL-6 | 0.48 | 0.58 | 0.63 | 0.44 | 0.11 | 0.230 | 0.116 | 0.605 |
| IL-10 | 0.79 | 0.79 | 0.78 | 0.79 | 0.13 | 0.628 | 0.882 | 0.388 |
| IL-17 | 0.76 | 0.83 | 0.91 | 0.68 | 0.16 | 0.720 | 0.176 | 0.723 |
| IL-22 | 0.73 | 0.57 | 0.84 | 0.46 | 0.13 | 0.363 | 0.037 | 0.742 |
| Occludin | 1.50 | 1.21 | 1.21 | 1.50 | 0.27 | 0.684 | 0.226 | 0.225 |
| Claudin-3 | 1.39 | 1.16 | 1.05 | 1.50 | 0.22 | 0.573 | 0.007 | 0.260 |
| ZO-15 | 0.25 | 0.24 | 0.21 | 0.29 | 0.05 | 0.281 | 0.067 | 0.803 |
1Ileal tissue samples were collected on day 28.
2 n = 24 per treatment.
3Xylanase activity was expected to be 15,000 EPU/g and the inclusion rate of X was 0.01% according to the manufacturer’s recommendation.
4One gram EB was expected to contain 7,000 CU of cellulase, 5,000 U of β-glucanase, and 1,000 EPU of xylanase; the inclusion rate of EB was 0.01% according to the manufacturer’s recommendation.
5ZO-1 = zonula occluden-1.